BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TxCell 

Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014 8:26:52 AM
TxCell To Lead Positive Project To Automate First Production Step Of Ovasave®, Its Lead Personalised Cellular Immunotherapy 7/3/2014 8:47:12 AM
TxCell Participates At Two Key US Life Science Events: 2014 French Life Sciences Day, New York, US And 2014 Biotechnology Industry Organization (BIO) International Convention, San Diego, US 6/18/2014 9:03:38 AM
TxCell Granted Certificate Of GMP Compliance From ANSM For Cell Therapy Manufacturing Facility 6/12/2014 7:36:37 AM
TxCell Release: Col-Treg Granted Advanced Therapy Medicinal Product (ATMP) Classification By The European Medicines Agency 5/22/2014 10:11:51 AM
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At The 16th Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014, New York, U.S.A. 2/5/2014 7:41:33 AM
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At Biotech Showcase™ 2014, San Francisco, USA 1/10/2014 3:43:07 PM
TxCell Enters Col-Treg Into Full Development For The Rare Disease Autoimmune Uveitis 1/7/2014 12:07:26 PM
TxCell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 12/3/2013 9:16:52 AM
TxCell Announces Publication of CATS1 Study Results for Antigen-Specific Treg Therapy in Crohn's Disease in Gastroenterology 10/24/2012 11:03:54 AM
12